Inhibition of collagen-induced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito

Blood

Volumn 111, Issue 4, 2008, Pages 2007-2014

  Yoshida, Shigeto ^a   Sudo, Toshiki ^b   Niimi, Masashi ^c   Tao, Lian ^c   Sun, Bing ^c   Kambayashi, Junichi ^c   Watanabe, Hiroyuki ^a   Luo, Enjie ^a   Matsuoka, Hiroyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOPHELINE ANTIPLATELET PROTEIN; CALCIUM; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GLYCOPROTEIN VI; RECOMBINANT PROTEIN; SALIVA PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ANOPHELES STEPHENSI; ARTICLE; CALCIUM CELL LEVEL; CELL ADHESION; CONTROLLED STUDY; EX VIVO STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; INGESTION; INSECT BITE; MALARIA; MOSQUITO; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 41349102554     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-06-097824     Document Type: Article

References (45)

1. Ribeiro JM. Role of saliva in blood-feeding by arthropods. Annu Rev Entomol. 1987;32:463-478.
2. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234.
3. Ribeiro JM, Rossignol PA, Spielman A. Role of mosquito saliva in blood vessel location. J Exp Biol. 1984;108:1-7.
4. Ribeiro JM, Sarkis JJ, Rossignol PA, Spielman A. Salivary apyrase of Aedes aegypti: characterization and secretory fate. Comp Biochem Physiol B. 1984;79:81-86.
5. Francischetti IM, Valenzuela JG, Ribeiro JM. Anophelin: kinetics and mechanism of thro+mbin inhibition. Biochem. 1999;38:16678-16685.
6. Kappe SH, Kaiser K, Matuschewski K. The Plasmodium sporozoite journey: a rite of passage. Trends Parasitol. 2003;19:135-143.
7. Matuschewski K, Ross J, Brown SM, Kaiser K, Nussenzweig V, Kappe SH. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J Biol Chem. 2002;277:41948-41953.
8. Francischetti IM, Valenzuela JG, Pham VM, Garfield MK, Ribeiro JM. Toward a catalog for the transcripts and proteins (sialome) from the salivary gland of the malaria vector Anopheles gambiae. J Exp Biol. 2002;205:2429-2451.
9. Valenzuela JG, Francischetti IM, Pham VM, Garfield MK, Ribeiro JM. Exploring the salivary gland transcriptome and proteome of the Anopheles stephensi mosquito. Insect Biochem Mol Biol. 2003;33:717-732.
10. Calvo E, Andersen J, Francischetti IM, et al. The transcriptome of adult female Anopheles darlingi salivary glands. Insect Mol Biol. 2004;13:73-88.
11. Yoshida S, Watanabe H. Robust salivary gland-specific transgene expression in Anopheles stephensi mosquito. Insect Mol Biol. 2006;15:403-410.
12. Brummer-Korvenkontio H, Palosuo T, Francois G, Reunala T. Characterization of Aedes communis, Aedes aegypti and Anopheles stephensi mosquito saliva antigens by immunoblotting. Int Arch Allergy Immunol. 1997;112:169-174.
13. Jariyapan N, Choochote W, Jitpakdi A, et al. A glycine- and glutamate-rich protein is female salivary gland-specific and abundant in the malaria vector Anopheles dirus B (Diptera: Culicidae). J Med Entomol. 2006;43:867-874.
14. Winger LA, Tirawanchai N, Nicholas J, Carter HE, Smith JE, Sinden RE. Ookinete antigens of Plasmodium berghei. Appearance on the zygote surface of an Mr 21 kD determinant identified by transmission-blocking monoclonal antibodies. Parasite Immunol. 10:193-207, 1988.
15. Matsumoto Y, Takizawa H, Gong X, et al. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization. Thromb Res. 2007;119:319-329.
16. Coller BS, Beer JH, Scudder LE, Steinberg MH. Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood. 1989;74:182-192.
17. Yoshida S, Kobayashi T, Matsuoka H, et al. T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites. Blood. 2003;101:2300-2306.
18. Laemmli UK. Cleavage of structual proteins during the assembly of the head of the bacteriophage T4. Nature. 1970;227:680-685.
19. Yoshida S, Matsuoka H, Luo E, et al. A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut. Mol Biochem Parasitol. 1999;104:195-204.
20. Sudo T, Tachibana K, Toga K, et al. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochem Pharmacol. 2000;59:347-356.
21. Kappes JC, Wu X, Wakefield JK. Production of trans-lentiviral vector with predictable safety. Meth Mol Med. 2003;76:449-465.
22. Nakamura T, Jamieson GA, Okuma M, Kambayashi J, Tandon NN. Platelet adhesion to native type I collagen fibrils. Role of GPVI in divalent cation-dependent and -independent adhesion and thromboxane A2 generation. J Biol Chem. 1998;273:4338-4344.
23. Sudo T, Ito H, Hayashi H, Nagamura Y, Toga K, Yamada Y. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats. Thromb Haemost. 2007;97:665-672.
24. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-1445.
25. Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcaR and the natural killer receptors. J Biol Chem. 1999;274:29019-29024.
26. Nieswandt B, Brakebusch C, Bergmeier W, et al. Glycoprotein VI but not a2b1 integrin is essential for platelet interaction with collagen. EMBO J. 2001;20:2120-2130.
27. Asselin J, Gibbins JM, Achison M, et al. A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C g2 in platelets independent of the integrin a2b1. Blood. 1997;89:1235-1242.
28. Francischetti IM, Saliou B, Leduc M, et al. Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets. Toxicon. 1997;35:1217-1228.
29. Jandrot-Perrus M, Lagrue AH, Okuma M, Bon C. Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin a2b1. J Biol Chem. 1997;272:27035-27041.
30. Santoro SA, Rajpara SM, Staatz WD, Woods VL Jr. Isolation and characterization of a platelet surface collagen binding complex related to VLA-2. Biochem Biophys Res Commun. 1988;153:217-223.
31. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature. 1985;318:470-472.
32. 2+-dependent adhesion of platelets to collagen. J Cell Biol. 1989;108:1917-1924.
33. 2+-dependent and bivalent-cation-independent adhesion. Biochem J. 1990;268:481-486.
34. Jung SM, Moroi M. Platelets interact with soluble and insoluble collagens through characteristically different reactions. J Biol Chem. 1998;273:14827-14837.
35. Siljander P, Lassila R. Studies of adhesion-dependent platelet activation: distinct roles for different participating receptors can be dissociated by proteolysis of collagen. Arterioscler Thromb Vasc Biol. 1999;19:3033-3043.
36. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102:449-461.
37. 1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem. 2000;275:35-40.
38. Kini RM. Platelet aggregation and exogenous factors from animal sources. Curr Drug Targets Cardiovasc Haematol Disord. 2004;4:301-325.
39. Gardell SJ, Duong LT, Diehl RE, et al. Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator. J Biol Chem. 1989;264:17947-17952.
40. Furlan AJ, Eyding D, Albers GW, et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke. 2006;37:1227-1231.
41. Witt W, Baldus B, Bringmann P, Cashion L, Donner P, Schleuning WD. Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats. Blood. 1992;79:1213-1217.
42. Deckmyn H, Stassen JM, Vreys I, Van Houtte E, Sawyer RT, Vermylen J. Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters. Blood. 1995;85:712-719.
43. Harsfalvi J, Stassen JM, Hoylaerts MF, et al. Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions. Blood. 1995;85:705-711.
44. Fareed J, Callas D, Hoppensteadt DA, Lewis BE, Bick RL, Walenga JM. Antithrombin agents as anticoagulants and antithrombotics: implications in drug development. Semin Hematol. 1999;36:42-56.
45. Tardy B, Lecompte T, Boelhen F, et al. Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood. 2006;108:1492-1496.